Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTI-ADIPONECTIN RECEPTOR ANTIBODY AND UTILIZATION OF SAME
Document Type and Number:
WIPO Patent Application WO/2024/096022
Kind Code:
A1
Abstract:
Provided is an anti-adiponectin antibody or an antibody fragment thereof in which LCDR1 includes an amino acid sequence of SEQ ID NO: 17 or 18, LCDR2 includes an amino acid sequence of SEQ ID NO: 19 or 20, LCDR3 includes an amino acid sequence of SEQ ID NO: 21, HCDR1 includes an amino acid sequence of SEQ ID NO: 22, HCDR2 includes an amino acid sequence of SEQ ID NO: 23, and HCDR3 includes an amino acid sequence of SEQ ID NO: 24.

Inventors:
ASAHARA NAOMI (JP)
WADA KOICHI (JP)
YAMAUCHI TOSHIMASA (JP)
IWABU MIKI (JP)
KADOWAKI TAKASHI (JP)
IWABU MASATO (JP)
Application Number:
PCT/JP2023/039323
Publication Date:
May 10, 2024
Filing Date:
October 31, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MITSUBISHI TANABE PHARMA CORP (JP)
UNIV TOKYO (JP)
International Classes:
C12N15/13; A61K39/395; A61P3/06; A61P3/10; C07K16/28; C07K16/46; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/63
Domestic Patent References:
WO2017086419A12017-05-26
Foreign References:
US20220249458A12022-08-11
Other References:
JUNG DOKYUNG; BUCHER FELICITAS; RYU SUYEON; JEONG JONGWON; LEE BEOM YONG; JEONG YOUNGTAE; KIM MINSEOK S.; OH YONG-SEOK; BAEK MOON-: "An adiponectin receptor agonist antibody stimulates glucose uptake and fatty-acid oxidation by activating AMP-activated protein kinase", CYTOKINE, ACADEMIC PRESS LTD, PHILADELPHIA, PA, US, vol. 126, 16 October 2019 (2019-10-16), US , XP085973005, ISSN: 1043-4666, DOI: 10.1016/j.cyto.2019.154863
Attorney, Agent or Firm:
IP FIRM SHUWA (JP)
Download PDF: